Final results of multicenter prospective observational study of nano-liposomal irinotecan, fluorouracil and folinic acid in second-line chemotherapy for advanced pancreatic cancer: The NAPOLEON-2

被引：0

作者：

Toyodome, K. ^{[1
]}

Arima, S. ^{[1
]}

Shimokawa, M. ^{[2
]}

Otsuka, T. ^{[3
]}

Nakazawa, J. ^{[4
]}

Shimokawa, H. ^{[5
]}

Koga, F. ^{[6
]}

Oda, H. ^{[7
]}

Takeshita, S. ^{[8
]}

Kawaguchi, Y. ^{[9
]}

Arita, S. ^{[10
]}

Nishikawa, K. ^{[11
]}

Jikuya, K. ^{[12
]}

Sakai, T. ^{[13
]}

Sawase, H. ^{[14
]}

Ueda, Y. ^{[15
]}

Araki, N. ^{[16
]}

Shirakawa, T. ^{[17
]}

Mizuta, T. ^{[18
]}

Mitsugi, K. ^{[19
]}

机构：

[1] Kagoshima Univ, Digest & Lifestyle Dis, Grad Sch Med & Dent Sci, Kagoshima, Japan

[2] Yamaguchi Univ, Dept Biostat, Grad Sch Med, Yamaguchi, Japan

[3] Minato Med Clin, Dept Internal Med, Fukuoka, Japan

[4] Kagoshima City Hosp, Dept Med Oncol, Kagoshima, Japan

[5] Japan Community Healthcare Org Kyushu Hosp, Dept Hematol Oncol, Fukuoka, Japan

[6] Saga Ken Med Ctr Koseikan, Dept Hepatobiliary & Pancreatol, Saga, Japan

[7] Saiseikai Kumamoto Hosp, Div Integrat Med Oncol, Kumamoto, Fukuoka, Japan

[8] Japanese Red Cross Nagasaki Genbaku Hosp, Dept Gastroenterol, Nagasaki, Japan

[9] Asakura Med Assoc Hosp, Dept Gastroenterol, Fukuoka, Japan

[10] Miyazaki Prefectural Miyazaki Hosp, Dept Chemotherapy, Miyazaki, Japan

[11] Oita Univ, Dept Med Oncol & Hematol, Fac Med, Oita, Japan

[12] Imamura Gen Hosp, Dept Gastroenterol, Kagoshima, Japan

[13] Natl Hosp Org Kumamoto Med Ctr, Dept Med Oncol, Kumamoto, Japan

[14] Natl Hosp Org Saga Hosp, Dept Internal Med, Saga, Japan

[15] Japanese Red Cross Kumamoto Hosp, Dept Hematol & Oncol, Kumamoto, Japan

[16] Saiseikai Sendai Hosp, Dept Gastroenterol, Kagoshima, Japan

[17] Clin Hematol Oncol Treatment Study Grp, Fukuoka, Japan

[18] Fujikawa Hosp, Dept Internal Med, Saga, Japan

[19] Sasebo Kyosai Hosp, Dept Med Oncol, Nagasaki, Japan

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.05.488

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

346P

引用

页码：S144 / S144

页数：1

共 50 条

[21] Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study
Se Jun Park
Hyunho Kim
Kabsoo Shin
Tae Ho Hong
Ja Hee Suh
Myung Ah Lee
BMC Cancer, 21
[22] Comparison of inflammatory markers before and after nanoliposomal irinotecan and fluorouracil with folic acid in patients with pancreatic cancer: results from the NAPOLEON-2 study (NN-2302)
Araki, Tomonori
Hayashi, Kohei
Shimokawa, Mototsugu
Otsuka, Taiga
Sonoda, Yuki
Honda, Takuya
Shibuki, Taro
Nakazawa, Junichi
Arima, Shiho
Miwa, Keisuke
Koga, Futa
Ueda, Yujiro
Kubotsu, Yoshihito
Shimokawa, Hozumi
Takeshita, Shigeyuki
Nishikawa, Kazuo
Komori, Azusa
Otsu, Satoshi
Hosokawa, Ayumu
Sakai, Tatsunori
Oda, Hisanobu
Kawahira, Machiko
Arita, Shuji
Taguchi, Hiroki
Tsuneyoshi, Kengo
Fujita, Toshihiro
Sakae, Takahiro
Kawaguchi, Yasunori
Shirakawa, Tsuyoshi
Mizuta, Toshihiko
Mitsugi, Kenji
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2025, 17
[23] Efficacy of second-line chemotherapy after standard combination chemotherapy in patients with metastatic pancreatic cancer: The results from the NAPOLEON study
Fukahori, Masaru
Okabe, Yoshinobu
Shimokawa, Mototsugu
Otsuka, Taiga
Koga, Futa
Ueda, Yujiro
Nakazawa, Junichi
Komori, Azusa
Arima, Shiho
Makiyama, Akitaka
Taguchi, Hiroki
Honda, Takuya
Ushijima, Tomoyuki
Miwa, Keisuke
Shibuki, Taro
Nio, Kenta
Ide, Yasushi
Ureshino, Norio
Mitsugi, Kenji
Shirakawa, Tsuyoshi
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[24] Efficacy and Safety of the Combination of Nano-Liposomal Irinotecan and 5-Fluorouracil/L-Leucovorin in Unresectable Advanced Pancreatic Cancer: A Real-World Study
Yasuoka, Hidetoshi
Naganuma, Atsushi
Kurihara, Eishin
Kobatake, Tsutomu
Ijima, Masashi
Tamura, Yuki
Suzuki, Yuhei
Hoshino, Takashi
Ishida, Fumiya
Hosaka, Hisashi
Hatanaka, Takeshi
Yoshida, Sachiko
Aihara, Ryusuke
Hosouchi, Yasuo
Ishii, Norihiro
Araki, Kenichiro
Shirabe, Ken
Uraoka, Toshio
Kakizaki, Satoru
ONCOLOGY, 2022, 100 (08) : 449 - 459
[25] Relationship between peripheral neuropathy and effectiveness in second-line chemotherapy for unresectable advanced gastric cancer: a prospective, observational, multicenter study protocol
Tanioka, H.
Nagasaka, T.
Uno, F.
Inoue, M.
Okita, H.
Katata, Y.
Kanzaki, H.
Kuramochi, H.
Satake, H.
Shindo, Y.
Doi, A.
Nasu, J.
Yamashita, H.
Yamaguchi, Y.
ANNALS OF ONCOLOGY, 2019, 30
[26] Biweekly irinotecan and cisplatin as second-line chemotherapy in pretreated patients with advanced gastric cancer: A multicenter phase II study
Baek, JH
Kim, JG
Sohn, SK
Kim, DH
Lee, KB
Song, HS
Kwon, KY
Do, YR
Ryoo, HM
Bae, SH
Park, KU
Kim, MK
Lee, KH
Hyun, MS
Chung, HY
Yu, W
JOURNAL OF KOREAN MEDICAL SCIENCE, 2005, 20 (06) : 966 - 970
[27] Electronic patient-reported outcome measured in patients with pancreatic cancer receiving second-line chemotherapy: A multicenter prospective observational study.
Ohba, Akihiro
Takumoto, Yuki
Terashima, Takeshi
Ueno, Makoto
Kobayashi, Satoshi
Ikezawa, Kenji
Okano, Naohiro
Fujimori, Nao
Tsumura, Hidetaka
Murohisa, Go
Ohya, Ayano
Yamashita, Tatsuya
Ozaka, Masato
Ikeda, Masafumi
Okusaka, Takuji
Morizane, Chigusa
Narimatsu, Hiroto
Akazawa, Manabu
Shiroiwa, Takeru
Furuse, Junji
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 682 - 682
[28] Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxel
Shibuki, Taro
Otsuka, Taiga
Shimokawa, Mototsugu
Nakazawa, Junichi
Arima, Shiho
Fukahori, Masaru
Miwa, Keisuke
Okabe, Yoshinobu
Koga, Futa
Ueda, Yujiro
Kubotsu, Yoshihito
Makiyama, Akitaka
Shimokawa, Hozumi
Takeshita, Shigeyuki
Nishikawa, Kazuo
Komori, Azusa
Otsu, Satoshi
Hosokawa, Ayumu
Sakai, Tatsunori
Oda, Hisanobu
Kawahira, Machiko
Arita, Shuji
Honda, Takuya
Taguchi, Hiroki
Tsuneyoshi, Kengo
Kawaguchi, Yasunori
Fujita, Toshihiro
Sakae, Takahiro
Nio, Kenta
Ide, Yasushi
Ureshino, Norio
Shirakawa, Tsuyoshi
Mizuta, Toshihiko
Mitsugi, Kenji
SCIENTIFIC REPORTS, 2024, 14 (01):
[29] The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)
Tanioka, Hiroaki
Nagasaka, Takeshi
Uno, Futoshi
Inoue, Masafumi
Okita, Hiroyuki
Katata, Yosuke
Kanzaki, Hiromitsu
Kuramochi, Hidekazu
Satake, Hironaga
Shindo, Yoshiaki
Doi, Akira
Nasu, Jyunichiro
Yamashita, Haruhiro
Yamaguchi, Yoshiyuki
BMC CANCER, 2019, 19 (01)
[30] The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)
Hiroaki Tanioka
Takeshi Nagasaka
Futoshi Uno
Masafumi Inoue
Hiroyuki Okita
Yosuke Katata
Hiromitsu Kanzaki
Hidekazu Kuramochi
Hironaga Satake
Yoshiaki Shindo
Akira Doi
Jyunichiro Nasu
Haruhiro Yamashita
Yoshiyuki Yamaguchi
BMC Cancer, 19

← 1 2 3 4 5 →